A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We describe an immunofluorescence procedure to detect markers of cellular senescence in human formalin-fixed, paraffin-embedded brain sections. In contrast to immunohistochemistry, immunofluorescence permits semi-quantitative measurements and multiple staining on the same slide, which allows detecting different cell types more rigorously and assessing the abundance of senescence markers more objectively.

Abstract

Cellular senescence is a terminal arrest in proliferation associated with aging and age-related diseases. Senescent cells are characterized in vitro by several morphological and biochemical markers, such as flattened morphology, Senescence-Associated beta-galactosidase activity, chromatin rearrangements, and expression of the cyclin-dependent kinase-inhibitors p21 and p16INK4A.

Here we describe a procedure to detect p16INK4A-positive cells by immunofluorescence on formalin-fixed, paraffin-embedded, human-brain specimens. Briefly, tissue slides are deparaffinated, rehydrated, and subjected to antigen-retrieval with standard immunohistochemistry procedures. The slides are then incubated with serum to block non-specific binding sites, and with primary antibodies against p16INK4A and a specific cell type marker. Finally, the slides are stained with fluorescently-conjugated secondary antibodies and counterstained with DAPI. This technique has been used successfully to detect p16INK4A positive astrocytes in human brains, but can be easily applied to other cell types, markers, and tissues, provided no cross-reactivity ensues between the antibodies.

Our technique allows for the identification of subpopulations of senescent cells more rigorously than immunohistochemistry and enables the user to measure the abundance of a senescence marker semi-quantitatively.

Introduction

Cellular senescence is a terminal arrest in cell proliferation 1 in response to telomere attrition, DNA damage, oncogenic activation, and oxidative stress 2,3 . Cells expressing markers of senescence have been found in vivo in skeletal muscle, lung and liver of old animals 4 and recently we have demonstrated the presence of senescent astrocytes in human brain 5. Senescent cells contribute to the aging process and to the onset of age-related pathologies by secreting several pro-inflammatory cytokines 6, a phenomenon known as Senescence-Associated Secretory Phenotype (SASP) 7. At the cellular level, senescence is characterized by several distinctive markers, such as senescence-associated β-galactosidase activity 8, accumulation of heterochromatin protein 1 and of the histone variant macro H2A 9,10 , secretion of interleukin 6 and matrix metalloproteinase 1 5,7 , and increased expression of the cyclin-dependent kinase-inhibitor p16INK4A. Although these markers are not exclusive to senescent cells, expression of p16INK4A is considered to be a robust indicator of cellular senescence in vivo 11 and has been used successfully in human specimens 5,11 . p16INK4A-expressing cells appear to be a critical factor in age-related pathologies: p16INK4A-positive astrocytes accumulate in human brains affected by Alzheimer's disease 5, and clearing p16INK4A-expressing cells delays aging in rodents 12.

We describe here a method for detecting cells expressing p16INK4A in formalin-fixed, paraffin-embedded (FFPE), human-brain specimens by immunofluorescence 5. Our protocol offers several advantages in comparison to immunofluorescence on frozen sections or immunohistochemistry: i) it can be used on tissues from most pathology autopsy archives (we provide an example on frontal cortex autopsy-specimen archival-tissue), ii) it is suitable for multiple staining on the same tissue slide, thus allowing discrimination between cell types based on the expression of specific cell markers, iii) it can be coupled with regular immunohistochemistry and thus with staining protocols clinically approved for diagnostic use.

Protocol

Human Subjects Ethics Statement

This research was performed in compliance with and following approval by the Institutional Review Board at Drexel University College of Medicine (Protocol Number: 18172), and the Institutional Review Board at University of Pennsylvania (Protocol Number: 180600). All tissue samples were de-identified and no protected health information was made available to the researchers; therefore, this protocol was approved as exempt study and consent was waived.

1. Deparaffination and Rehydration of Tissue Sections

Note: Once the protocol has been started, ensure that the slides are never allowed to dry out because this could interfere with quality of the staining.

  1. Deparaffinize tissue sections on glass slides by immersing slides into a glass dish filled with xylene for 5 min (CAUTION: Use only under a chemical fume hood, possible cancer hazard). Transfer slides to the next dish filled with fresh xylene and incubate for 5 min and repeat this step once more for a total of 3 incubations of 5 min each. Keep track of how often the xylene in each container was used and properly discard of xylene after 3 uses.

Note: Set up and turn on heat steamer as described in point 2.2

  1. Transfer slides to the next dish filled with 100% alcohol (CAUTION: flammable) and wash for 5 min. Repeat once more with fresh 100% alcohol for a total of 2 X 5-minute washes.
  2. Prepare 90% alcohol by diluting with deionized water (i.e. 90 ml of alcohol + 10 ml of deionized water). Incubate slides in 90% Reagent Alcohol for 5 min. Repeat once more with fresh 90% alcohol for a total of 2 X 5-minute washes.
  3. Prepare 80% alcohol by diluting with deionized water. Incubate slides in 80% alcohol for 5 min. Repeat once more with fresh 80% alcohol for a total of 2 X 5-minute washes.
  4. Prepare 70% alcohol by diluting with deionized water. Incubate slides in 70% Reagent Alcohol for 5 min. Repeat once more with fresh 70% alcohol for a total of 2 X 5-minute washes.
  5. Incubate slides in deionized water for 5 min. Repeat once more with fresh deionized water for a total of 2 X 5-minute washes.

2. Antigen Retrieval

  1. Transfer slides to a horizontal slide holder filled with 10 mM citrate buffer pH 6.0. Equilibrate slides in this buffer for 5 min. Prepare 10 mM citrate buffer pH 6.0 by diluting from 100 mM stock of citrate buffer. For 1L of 100 mM citrate buffer stock pH 6.0, dilute 21.01 g of citric acid monohydrate (formula weight 210.14 g/mol) in distilled deionized water, bring the pH to 6.0 with a solution of NaOH, and then adjust the volume to 1L.
  2. Heat-steam slides in a covered dish filled with citrate buffer for 15-20 min depending on the degree of cross-linking of the tissue sample. Heat steamer (rice cooker) should be set-up and turned on during deparaffination steps by filling lower chamber approximately halfway with distilled water.
  3. Remove covered dish with slides in citrate buffer from heat (CAUTION: dish will be hot) and place on lab bench top for at least 30 min.
  4. Wash slides 2 X 5 min in 1X PBS 0.1% BSA solution. (For 1 L of 1X PBS-0.1%BSA solution, add 1 g of bovine serum albumin (BSA) to 1 L of phosphate-buffered saline (1X PBS) and mix well to dissolve BSA).

3. Blocking

  1. Prepare a humidified chamber by placing filter paper in the bottom of a plastic slide box and moistening with deionized water.
  2. Prepare blocking solution to a final concentration of 0.1% BSA (w/v) 0.25% Triton X-100 (v/v), 5% normal goat serum (v/v), and 5% normal donkey serum (v/v) in 1X PBS. The type of serum used in the blocking solution will depend on the species in which the secondary antibodies were raised (i.e. If using donkey anti mouse secondary antibody and goat anti rabbit secondary, block with donkey and goat serums simultaneously).
  3. Remove slides one at a time from the PBS-BSA wash and wipe away excess liquid from the back and edges of the slide. Avoid making any contact with the tissue section.
  4. Place slide in humidified chamber. Draw a hydrophobic border around the outside of the tissue section with a PAP pen. When circumscribing tissue area, ensure that area through which the line is drawn is completely dry; otherwise the border may be lost during immunostaining. Avoid putting too much pressure on the pen, which could result in excess solution being discharged onto the slide.
  5. Immediately add enough blocking solution to cover the tissue. Use approximately 100-200 microliters per tissue section, depending on the surface area. Avoid contacting the tissue section with the pipette tip. Repeat for all slides.
  6. Incubate slides with blocking solution for 90 min in the humidified chamber at room temperature.

4. Immunoflourescence Staining with Two Primary Antibodies Simultaneously

  1. For immunostaining with more than one primary antibody simultaneously, (i.e. a senescence biomarker (mouse anti-p16INK4A) and a cellular biomarker (rabbit anti-GFAP (glial fibrillary acidic protein) to visualize astrocytes), dilute primary antibodies to desired final concentration in antibody dilution buffer consisting of 1X PBS, 0.1% BSA (w/v), and 0.25% Triton X-100 (v/v) in the same 1.5 ml tube and mix well. See Discussion regarding selection of primary antibodies.
  2. Blot off blocking solution by pressing the edge of the slide against filter paper.
  3. Apply the solution of primary antibodies to each slide. Use approximately 75 microliters per slide or enough volume to cover depending on tissue surface area.
  4. Incubate in humidified chamber overnight (approximately 16 hr) at 4 degrees Celsius. Handle humidified chamber carefully to avoid displacing primary antibody solution from the tissue area.
  5. Blot off primary antibody by touching the edge of the slide to filter paper. Wash slides in 1X PBS 0.1% BSA for total of 3 x 5-minute washes.
  6. Prepare secondary antibodies (conjugated to different fluorochromes) by diluting to a final concentration of 1: 500 in antibody dilution buffer (see step 4.1). Incubate in the dark in a humidified chamber for 1 hr. The secondary antibodies are light-sensitive; therefore, this step and all subsequent steps should be protected from light.
  7. Blot off secondary antibody solution by touching the edge of the slide to filter paper. Wash slides in 1X PBS 0.1% BSA for total of 3 x 5-minute washes.
  8. Prepare DAPI working solution by diluting DAPI (50 μg/ml stock) 1:5000 with 1XPBS 0.1%BSA. Apply the DAPI working solution to the slides and incubate for 10 min in the dark.
  9. Rinse slides abundantly with at least 3-4 washes with distilled deionized water.

5. Mounting Slides for Immunofluorescence Microscopy

  1. Remove slides one at a time from the water wash and wipe away excess liquid from the back of the slide. Avoid making any contact with the tissue section.
  2. Place a drop (approximately 10 microliters) of fluorescence mounting medium in the center of the tissue section. Avoid using too much mounting medium, otherwise the coverslip will move against the tissue section and it will be difficult to seal the edges.
  3. Place a glass coverslip (24 x 50 mm) on edge of slide and slowly lower onto the tissue section to avoid generating bubbles.
  4. Seal coverslips with clear nail polish by first putting a drop of nail polish at one corner of the slide with coverslip and dry undisturbed for approximately 5 min. Seal the remaining corners with nail polish and then seal the short and long edges of the coverslip. Allow nail polish to try before going to the microscope.
  5. Store stained slides at 4 degrees Celsius and visualize within two weeks.

6. Image Acquisition and Analysis

Using a fluorescence microscope, capture images using the appropriate channels depending on the fluorochromes used.

OPTIONAL: Combined Immunohistochemistry and Immunofluorescence

Prior to immunofluorescence staining, immunohistochemistry can be performed in the same tissue section for an additional marker. Following antigen retrieval (Step 2), sections can be stained using standard immunohistochemical methods in the absence of a counterstain. Slides are visualized with the fluorescence microscope and captured in brightfield.

Results

We demonstrate a method for detecting a senescence biomarker within a specific cell type in situ in archived FFPE human brain tissue. Figure 1 shows representative images of p16INK4A and GFAP staining in AD patient and an age-matched control subject. We demonstrate that p16INK4A staining is diffusely localized throughout the nucleus, while GFAP staining is cytoplasmic. Nuclear p16INK4A staining is considered positive when it colocalizes with DAPI and the signal inte...

Discussion

Double immunofluorescence labeling of human brain tissues is a well-established method in the study of neurodegenerative disease 13-15 and methods for performing immunofluorescence on FFPE tissues have been described previously 16, thus we redirect the reader to them for a more detailed discussion of the technique, while we will focus on key concepts necessary for applying the technique successfully to detect senescent cells. Background signal and antibody specificity are the most critical ch...

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

The study was supported by grants NIH/NINDS 1RO1NS078283-01 (FBJ, JQT, CT), NIH/NIA AG022443 (CS) and AG022443-S1 (CT). EPC was supported by NIH 1F30AG043307-01 grant and by the Department of Pathology, Drexel University College of Medicine. AB was supported by the Aging Initiative Fellowship, Drexel University College of Medicine. RB was supported by the Resident Research Fellowship, Drexel University College of Medicine.

Materials

NameCompanyCatalog NumberComments
Name of Reagent/MaterialCompanyCatalog NumberComments
XyleneFisher ScientificX3P-1GALhistological grade, flammable
Reagent AlcoholFisher ScientificA962F-1GALflammable liquid
Citric acid monohydrateSigma AldrichC7129-500Geye irritant
Phosphate-buffered SalineMediatech46-013-CM10X
Bovine Serum AlbuminGemini Bioproducts700-101P
Triton X-100Sigma AldrichT-9284irritant
ImmEdge Pen (PAP pen)Vector LaboratoriesH-4000
Goat SerumMP Biomedicals191356
Donkey SerumMilliporeS30-100ML
Mouse anti p16 antibodySanta Cruz Biotechnologysc-1661
Rabbit anti GFAP antibodyMilliporeAB5804
Alexa Fluor 488 Goat Anti-Rabbit IgG (H+L)Life TechnologiesA-11008
Alexa Fluor 555 Donkey Anti-Mouse IgG (H+L)Life TechnologiesA31570
DAPI (4′,6-Diamidino-2-phenylindole dihydrochloride)Sigma Aldrich32670-5MG-F
Vectashield Mounting Medium Vector LaboratoriesH-1000
CoverslipsFisher Scientific 12-544-1424x50 mm
Clear nail polishAny supplier
Heat steamerAny supplierrice cooker
Olympus BX61 fluorescence microscopeOlympus
Hamamatsu ORCA-ER camera
Slide Book 4 Software Intelligent Innovations, Incversion 4.0.1.44

References

  1. Hayflick, L. The limited in vitro lifetime of human diploid strains. Exp. Cell Res. 37, 614-636 (1965).
  2. Rodier, F. & Campisi, J. Four faces of cellular senescence. The Journal of cell biology 192, 547-603, doi:10.1083/jcb.201009094 (2011).
  3. Iwasa, H., Han, J., & Ishikawa, F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells. 8, 131-144, doi:620 [pii] (2003).
  4. Kreiling, J., et al. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell. 10, 292-304, doi:10.1111/j.1474-9726.2010.00666.x (2011).
  5. Bhat, R., et al. Astrocyte senescence as a component of Alzheimer's disease. PLoS One. 7, doi:10.1371/journal.pone.0045069 (2012).
  6. Campisi, J., Andersen, J.K., Kapahi, P., & Melov, S. Cellular senescence: a link between cancer and age-related degenerative disease? Seminars in cancer biology. 21, 354-359, doi:10.1016/j.semcancer.2011.09.001 (2011).
  7. Coppe, J.P., et al. A role for fibroblasts in mediating the effects of tobacco-induced epithelial cell growth and invasion. Molecular cancer research : MCR. 6, 1085-1098, doi:6/7/1085 [pii] 10.1158/1541-7786.MCR-08-0062 (2008).
  8. Dimri, G.P., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America. 92, 9363-9367 (1995).
  9. Zhang, R., et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 8, 19-30, doi:10.1016/j.devcel.2004.10.019 (2005).
  10. Adams, P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene. 397, 84-93, doi:S0378-1119(07)00190-4 [pii] 10.1016/j.gene.2007.04.020 (2007).
  11. Ressler, S., et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 5, 379-389, doi:10.1111/j.1474-9726.2006.00231.x (2006).
  12. Baker, D., et al. Clearance of p16(Ink4a)-positive senescent cells delays ageing-associated disorders. Nature. (2011).
  13. Neumann, M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 314, 130-133, doi:10.1126/science.1134108 (2006).
  14. Uryu, K., et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. Journal of neuropathology and experimental neurology. 67, 555-564, doi:10.1097/NEN.0b013e31817713b5 (2008).
  15. Irwin, D.J., et al. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain : a journal of neurology. 135, 807-818, doi:10.1093/brain/aws013 (2012).
  16. Robertson, D., Savage, K., Reis-Filho, J.S., & Isacke, C.M. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC cell biology. 9, 13, doi:10.1186/1471-2121-9-13 (2008).
  17. Sawicka, M., et al. The Specificity and Patterns of Staining in Human Cells and Tissues of p16INK4a Antibodies Demonstrate Variant Antigen Binding. PLoS One. 8, doi:10.1371/journal.pone.0053313 (2013).
  18. Lukas, J., et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375, 503-506, doi:10.1038/375503a0 (1995).
  19. Haller, F., et al. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). The Journal of pathology. 215, 253-262, doi:10.1002/path.2352 (2008).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Brain DiseasesAlzheimer DiseaseNeurodegenerative DiseasesAlzheimer DiseaseAgingPrematureNeuroimagingCell AgingAgingPathological ConditionsSigns and SymptomsImmunofluorescencep16INK4Abrainsenescenceneuroscienceastrocytesaging

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved